167 related articles for article (PubMed ID: 11748216)
21. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
Horstrup K; Jablonka B; Hönig-Liedl P; Just M; Kochsiek K; Walter U
Eur J Biochem; 1994 Oct; 225(1):21-7. PubMed ID: 7925440
[TBL] [Abstract][Full Text] [Related]
23. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
[TBL] [Abstract][Full Text] [Related]
24. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
Eigenthaler M; Nolte C; Halbrügge M; Walter U
Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
[TBL] [Abstract][Full Text] [Related]
25. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets.
Walter U; Eigenthaler M; Geiger J; Reinhard M
Adv Exp Med Biol; 1993; 344():237-49. PubMed ID: 8209791
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
Jensen BO; Selheim F; Døskeland SO; Gear AR; Holmsen H
Blood; 2004 Nov; 104(9):2775-82. PubMed ID: 15265792
[TBL] [Abstract][Full Text] [Related]
27. p-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation.
Kamruzzaman SM; Yayeh T; Ji HD; Park JY; Kwon YS; Lee IK; Kim S; Oh SH; Kim SD; Roh SS; Yun BS; Rhee MH
Vascul Pharmacol; 2013; 59(3-4):83-9. PubMed ID: 23872194
[TBL] [Abstract][Full Text] [Related]
28. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
[TBL] [Abstract][Full Text] [Related]
29. Effects of anagrelide on platelet cAMP levels, cAMP-dependent protein kinase and thrombin-induced Ca++ fluxes.
Seiler S; Arnold AJ; Grove RI; Fifer CA; Keely SL; Stanton HC
J Pharmacol Exp Ther; 1987 Nov; 243(2):767-74. PubMed ID: 2824759
[TBL] [Abstract][Full Text] [Related]
30. Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity.
Lim DG; Sweeney S; Bloodsworth A; White CR; Chumley PH; Krishna NR; Schopfer F; O'Donnell VB; Eiserich JP; Freeman BA
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15941-6. PubMed ID: 12444258
[TBL] [Abstract][Full Text] [Related]
31. Aged Garlic Extract Inhibits Human Platelet Aggregation by Altering Intracellular Signaling and Platelet Shape Change.
Rahman K; Lowe GM; Smith S
J Nutr; 2016 Feb; 146(2):410S-415S. PubMed ID: 26764324
[TBL] [Abstract][Full Text] [Related]
32. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of anti-platelet activity of Oligoporus tephroleucus oligoporin A: involvement of extracellular signal-regulated kinase phosphorylation and cyclic nucleotide elevation.
Park JY; Oh WJ; Kim MJ; Kim TH; Cho JY; Park HJ; Lee IK; Kim S; Kim GS; Kim SK; Seo GS; Yun BS; Rhee MH
Platelets; 2012; 23(5):376-85. PubMed ID: 22309049
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets.
Libersan D; Rousseau G; Merhi Y
Thromb Haemost; 2003 Feb; 89(2):310-7. PubMed ID: 12574812
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
Manns JM; Brenna KJ; Colman RW; Sheth SB
Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
[TBL] [Abstract][Full Text] [Related]
36. Multifaceted effects of arachidonic acid and interaction with cyclic nucleotides in human platelets.
Rukoyatkina N; Shpakova V; Panteleev M; Kharazova A; Gambaryan S; Geiger J
Thromb Res; 2018 Nov; 171():22-30. PubMed ID: 30240944
[TBL] [Abstract][Full Text] [Related]
37. Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP.
Lee DH; Kwon HW; Kim HH; Lim DH; Nam GS; Shin JH; Kim YY; Kim JL; Lee JJ; Kwon HK; Park HJ
Arch Pharm Res; 2015 Jan; 38(1):81-97. PubMed ID: 25001901
[TBL] [Abstract][Full Text] [Related]
38. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
[TBL] [Abstract][Full Text] [Related]
39. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
Li Z; Ajdic J; Eigenthaler M; Du X
Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
[TBL] [Abstract][Full Text] [Related]
40. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]